feed,title,long_url,short_url
Benzinga,Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients,https://benzinga.com/general/biotech/22/03/26393424/portage-biotech-shares-encouraging-preliminary-safety-data-from-lead-inkt-agonists-program-in-can,https://bit.ly/3wPsF1V
